Coherus BioSciences inks $558.4M deal with Intas Pharmaceuticals; shares rally By Investing.com

Shares of Coherus BioSciences surged in premarket trading following the announcement of a deal to sell its Udencya franchise to Intas Pharmaceuticals. The agreement, valued at up to $558.4 million, includes an initial cash payment of $483.4 million to Coherus, along with two additional milestone payments tied to net sales, each worth $75 million. Coherus … Read more

Joe Biden’s selfish parting act

Unlock the White House Watch newsletter for free Your guide to what the 2024 US election means for Washington and the world It was shocking enough that Donald Trump picked one of his daughters’ fathers-in-law to be US ambassador to France and another as his Middle East envoy. The first, Charles Kushner, father of Jared, … Read more

Mobile games see high returns on hybrid monetization models | AppsFlyer

AppsFlyer released its 2024 State of App Monetization report today, which offers mobile developers insight into different monetization models and their returns over time for both gaming and non-gaming apps. According to the company’s findings, apps can benefit from hybrid or diversified revenue streams, and a collaborative approach between marketing and monetization teams will be … Read more